公开(公告)号：EP1538200A4

公开(公告)日：2007-06-06

申请号：EP03752940

申请日：2003-05-22

申请人： FUSHIMI PHARMACEUTICAL COMPANY ,  TEIKOKU SEIYAKU KK ,  UNIV KAGAWA ,  SHIKOKU RESEARCH INST INC ,  HAYASHIBARA BIOCHEM LAB

发明人： IZUMORI KEN ,  TOKUDA MASAAKI ,  ITANO TOSHIFUMI ,  MIYAMOTO OSAMU ,  ISHIDA TOSHIHIKO ,  MURAO KOJI ,  TASAKA TAIZO ,  MUNEUCHI GAN ,  YAMAGUCHI FUMINORI ,  TANAKA TERUKAZU ,  HOSSAIN MOHAMMAD AKRAM ,  UEKI MASAAKI ,  HIROOKA KAZUYUKI ,  TAMINATO TOMOHIKO ,  TSUSAKI KEIJI ,  TAKAHASHI TAKEO ,  NAGATA MITSUHIRO ,  ISHIDA YUTAKA

IPC分类号： A23L1/09 ,  A23L1/30 ,  A61K8/60 ,  A61K31/7004 ,  A61Q19/00 ,  C12N5/08 ,  A61K7/00

CPC分类号： A61Q19/00 ,  A23L29/30 ,  A23L33/10 ,  A61K8/60 ,  A61K31/7004

摘要： A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.

公开(公告)号：EP1256346A4

公开(公告)日：2006-03-22

申请号：EP00981742

申请日：2000-12-15

申请人： TEIKOKU SEIYAKU KK

发明人： INAMOTO YUKIKO ,  KAWATA MITSUHIRO ,  KAWABATA SEIICHIRO ,  NAKAYAMA DAISUKE ,  HISAICHI SHIN-ICHI ,  TOKUDA MASAAKI

IPC分类号： A61K9/00 ,  A61K9/70 ,  A61K31/60 ,  A61K31/616 ,  A61K47/00 ,  A61P17/00 ,  A61P37/08 ,  A61K9/06

CPC分类号： A61K9/0014 ,  A61K9/7053 ,  A61K9/7061 ,  A61K9/7076 ,  A61K31/60 ,  A61K31/616

摘要： Remedies for external use for allergic skin diseases containing aspirin alone, which exerts an excellent therapeutic effect on allergic skin diseases with little side effects, as the active ingredient; and a method of treating allergic skin diseases by using these agents for external use.

摘要翻译： 含有阿司匹林单独作为活性成分的过敏性皮炎外用制剂，对过敏性皮炎具有较好的治疗作用，副作用较小; 以及通过使用这些外用剂来治疗过敏性皮炎的方法。

公开(公告)号：EP1249239A4

公开(公告)日：2006-04-05

申请号：EP00981741

申请日：2000-12-15

申请人： TEIKOKU SEIYAKU KK

发明人： INAMOTO YUKIKO ,  KAWATA MITSUHIRO ,  KAWABATA SEIICHIRO ,  NAKAYAMA DAISUKE ,  HISAICHI SHIN-ICHI ,  TOKUDA MASAAKI

IPC分类号： A61K31/60 ,  A61K9/06 ,  A61K9/70 ,  A61K31/616 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/18 ,  A61K47/26 ,  A61P17/04

CPC分类号： A61K9/0014 ,  A61K9/06 ,  A61K9/7053 ,  A61K9/7061 ,  A61K9/7076 ,  A61K31/616 ,  A61K47/10 ,  A61K47/12 ,  A61K47/14 ,  A61K47/18 ,  A61K47/26

摘要： Antipruritic agents for external use containing aspirin, which exerts an excellent therapeutic effect on itching with little side effects, as the active ingredient.